US › Healthcare

Curanex Pharmaceuticals Inc Common Stock (CURX)

US · Healthcare · Biotechnology

$0.21-0.99%

Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue

Net profit

$-3.2M

Profit YoY

-2189.7%

EPS

$-0.11

Key statistics

Market cap

$5.8M

Forward P/E

0.0

P/B

0.72

Book value

$0.01

EPS (TTM)

$-0.02

52-week high

$9.18

52-week low

$0.18

50-day MA

$0.27

200-day MA

$0.39

Shareholding

Insiders

67.81%

Largest institutional holders

Fund	Stake
Geode Capital Management, LLC	0.39%
TWO SIGMA SECURITIES, LLC	0.20%
XTX Topco Ltd	0.18%
Citadel Advisors Llc	0.18%
Two Sigma Investments LLC	0.07%
Citigroup Inc	0.07%
Jump Financial LLC	0.04%
UBS Group AG	0.03%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Curanex Pharmaceuticals Inc Common Stock — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc UnitedHealth Group Incorporated Merck & Company Inc Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Novo Nordisk A/S Amgen Inc Abbott Laboratories Gilead Sciences Inc

Data updated 2026-08-05.